Skip to main content
Clinical Trials/CTRI/2023/06/053844
CTRI/2023/06/053844Not yet recruitingPhase 2

A Comparative Study on the Efficacies of Joshanda Haleela Siyah with topical zimads in Qooba (Tinea Corporis )-A Randomized Single Blind Controlled Clinical Trial

ational Institute of Unani Medicine0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Clinically diagnosed cases of Tinea Corporis with less than or equal to 3% body surface area (calculated by the palm rule)Patients whose KOH is positive.
  • 2. Patient of either gender.
  • 3. Age group 18-60 years.
  • 4).Patient with controlled diabetes

Exclusion Criteria

  • 1.Known cases of tinea corporis on medication one month prior
  • 2. Patients of T. Corporis with more than 3% body surface area.
  • 3. Patients whose KOH is negative.
  • 4. Patients below and above the age of 18 and 60 years respectively.
  • 5. Patients suffering from concomitant skin diseases like psoriasis & Eczema and other types of tinea like T. Cruris, T. Facei, T.Capitis, T.Unguum, T.Manuum.
  • 6. Pregnant & Lactating Women.
  • 7. Known history of impaired hepatic, renal or cardiovascular functions in patients.
  • 8. Uncontrolled cases of Diabetes and other immunocompromised patients

Investigators

Sponsor
ational Institute of Unani Medicine

Similar Trials